Join to View Full Profile
3303 Sw Bond Ave7th FloorPortland, OR 97239
Phone+1 503-494-6594
Dr. Ryan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of ChicagoFellowship, Hematology and Medical Oncology, 1997 - 2000- University of ChicagoResidency, Internal Medicine, 1994 - 1997
SUNY Upstate Medical UniversityClass of 1994
Certifications & Licensure
ID State Medical License 2021 - 2025
OR State Medical License 2003 - 2025
IL State Medical License 1994 - 2005
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- Sorafenib, Epirubicin, Ifosfamide, and Radiation Therapy Followed By Surgery in Treating Patients With High-Risk Stage II or Stage III Soft Tissue Sarcoma Start of enrollment: 2009 Feb 01
- S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery Start of enrollment: 2011 Apr 01
- Pazopanib Hydrochloride Followed by Chemotherapy and Surgery in Treating Patients With Soft Tissue Sarcoma Start of enrollment: 2012 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- Dual anti-CTLA-4 and anti-PD-1 blockade in metastatic basal cell carcinoma.Sandip P Patel, Eleanor Cano-Linson, Young Kwang Chae, Shiruyeh Schokrpur, Christopher D Lao
NPJ Precision Oncology. 2025-01-24 - A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors SWOG S1609: Vulvar Cancers.Young Kwang Chae, Lucy Corthell, Sandip Pravin Patel, Robert Edwards, Jennifer M Scalici
Clinical Cancer Research. 2025-01-17 - 1 citationsA phase 4, multicenter, global clinical study to evaluate discontinuation and rechallenge of pexidartinib in patients with tenosynovial giant cell tumor previously tre...Jayesh Desai, Andrew J Wagner, Irene Carrasco Garcia, Marilena Cesari, Michael Gordon
Cancer. 2025-01-01
Press Mentions
Analysis of Human Performance Deficiencies Associated with Surgical Adverse EventsJuly 3rd, 2019
SWOG Launches National Immunotherapy Clinical Trial for Rare CancersJanuary 18th, 2017
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
